Press Releases
September 29, 2025
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
July 2, 2025
The Pancreatic Cancer Action Network Announces Partnership with Acurion to Accelerate Pancreatic Cancer Diagnostics Using AI and Real-World Patient Data
May 3, 2025
Acurion Sets Its Gaze On A Leadership Position In The Field Of Precision Oncology Care
February 14, 2025
European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
February 12, 2025
Anaptys Announces Rosnilimab Achieved Positive Results in RA Phase 2b Trial and Highest Ever Reported CDAI LDA Response Over 6 Months
February 6, 2025
A Scientist’s Life: Daniel Wangpraseurt – Marine biologist creates bioengineering techniques to help coral recover
July 31, 2024
io9 Announces Publication in the Journal of Clinical Oncology Demonstrating Efficacy of OncoGaze™, its Next-Generation AI Platform Poised to Eliminate Delays and Inequities in Correct First-Line Precision Treatment Selection for Cancer Patients
August 14, 2023
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
June 13, 2023
ProciseDx Announces Acquisition by Biosynex S.A. to Transform Biologics Therapeutic Drug Monitoring in the US
January 19, 2023
Higher Education Meets Hollywood: ASU-Incubated VR Company Dreamscape Learn Raises $20M to Transform STEM Education
January 12, 2023
Alume Co-Founder Roger Tsien Inducted Into National Inventors Hall of Fame
January 10, 2023
Alume Biosciences Secures $13M In Series B Financing
January 10, 2023
Micronoma Receives FDA Breakthrough Device Designation for OncobiotaLUNG, A Novel Liquid Biopsy Assay for Lung Carcinoma Detection
January 9, 2023
Neuralace Medical Announces Contract Award Totaling $1.4M Over Five Years With The Department of Veterans Affairs, Augusta, Georgia VA for Treatment of Chronic Neuropathic Pain Using Axon Therapy®
January 9, 2023
Neuralace Medical Announces First Patients Enrolled in the AT-PDN Study Evaluating Axon Therapy® for the Treatment of Painful Diabetic Neuropathy
December 12, 2022
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
November 21, 2022
Graybug and CalciMedica Enter into Definitive Merger Agreement
November 08, 2022
ProciseDx Announces FDA Clearance of ProciseDx instrument and C Reactive Protein (CRP) Assay
November 1, 2022
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
August 23, 2022
Alume Biosciences Announces First Patient Dosed with ALM-488 in Phase 3 Pivotal Study in Patients Undergoing Head and Neck Surgery
May 26, 2022
New Study from Seraphina Therapeutics Finds that a Good Saturated Fat, C15:0, is Better, Broader and Safer than Omega-3
April 26, 2022
Castle Biosciences Completes Acquisition of AltheaDx
April 20, 2022
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
February 22, 2021
MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis
February 18, 2021
TransCode Therapeutics Announces Key Appointments
February 17, 2021
Micronoma Raises $3.5 Million in Convertible Note Financing
December 15, 2020
BioAtla Announces Pricing of Initial Public Offering
December 15, 2020
Castle Biosciences Announces Pricing of $232 Million Public Offering of Public Stock
December 9, 2020
Micronoma Establishes Scientific Advisory Board
November 5, 2020
Merck to Acquire VelosBio
October 15, 2020
Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
October 13, 2020
Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer
October 5, 2020
Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency
September 30, 2020
Micronoma Appoints Magda Marquet Chairman of the Board
September 29, 2020
ProciseDx Completes Distribution Agreements with D.I.D. in Italy and BHR in the United Kingdom
September 28, 2020
HUYA Bioscience International Announces Orphan Drug Designation for HBI-8000 Monotherapy Adult T-cell Leukemia-Lymphoma ATL in Japan
September 18, 2020
Dreamscape Immersive, ASU launch bold partnership to bring cutting-edge virtual reality to learners worldwide
September 9, 2020
ProciseDx Achieves CE Mark for Infliximab and Adalimumab Point of Care Testing
August 13, 2020
Micronoma Launches with $3 Million Seed Funding
August 10, 2020
Ligand to Acquire Pfenex Inc.
July 29, 2020
Arcturus Therapeutics Announces Pricing of $173 Million Public Offering of Common Stock
July 21, 2020
ProciseDx Secures $10.5 Million Series A Financing Round Led by Biosynex, Forms an Independent Point-Of-Care Diagnostic Company
July 21, 2020
Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19
July 15, 2020
BioAtla Raises $72.5 Million in Series D Financing
July 8, 2020
VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology
May 26, 2020
MatriSys Bioscience Inc. is Pleased to Announce that Magda Marquet PhD has been Appointed Chairwoman of MatriSys’ Board of Directors
May 22, 2020
CalciMedica Raises $15 Million in Series C Financing Round Led by Valence Life Sciences
May 21, 2020
CalciMedica Announces that FDA has Strongly Recommended Moving to a Blinded Placebo-Controlled Trial with Auxora™ in Patients with Severe Covid-19 Pneumonia
May 18, 2020
Seraphina Therapeutics – The First Potential Essential Fatty Acid Discovered in 90 Years
May 8, 2020
Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)
May 4, 2020
US FDA Allows Trial to Proceed for Alume Biosciences’ Nerve Imaging Candidate
May 1, 2020
Alume Biosciences Completes $5.5M Series A Financing
April 27, 2020
Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate
April 27, 2020
Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test
April 13, 2020
Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency
March 27, 2020
Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System
March 11, 2020
UCSD Team, and Micronoma Founders, Publish Nature Paper Identifying Nucleic Acid-Based, Tumor-Specific Microbial Signatures in the Blood, Suggesting a New Diagnostic Approach
March 4, 2020
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine Using STARR™ Technology
Articles
February 22, 2021
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial
October 11, 2020
San Diego biotechs have plunged into the fight against COVID-19. Here’s what they’re doing
July 9, 2020
Pandemic Perspectives – Interview with Magda Marquet
May 18, 2020
Arcturus Therapeutics and Duke-NUS – LUNAR-COV19
April 17, 2020
Governor Newsom Taps California Business, Labor, Health Care and Community Leaders for New Task Force on Business and Jobs Recovery
October 10, 2018
Scripps Research Creates Board of Overseers
February 13, 2017
La Jolla Institute Board of Directors Elects Biotech Entrepreneur
January 20, 2016
The San Diego Technology Archive – UCSD Libraries
December 17, 2015
Drs. Magda Marquet and Francois Ferré Selected as 2016 Inductees into the CONNECT Entrepreneur Hall of Fame
September 10, 2015
Executive Q&A: Magda Marquet of Althea Technologies and Alma Life Sciences
February 27, 2013
San Diego Source – Magda Marquet
almalifesciences.com 